AKT1 and endocrine system disorder: Therefore, the restoration of BDNF/PI3K/Akt/mTOR expression by CYDXF may be attributed to, at least in part, the effects of regulating endocrine disorders and/or treating the depressive disorders of these bioactive compounds.